The American Heart Association (AHA) has announced a new initiative aimed at transforming care for individuals living with Fontan circulation, a result of a palliative surgical procedure for complex congenital heart disease. The Fontan procedure, while lifesaving for children born with single-ventricle defects, leads to a unique circulation that poses significant risks for complications in the liver, kidneys, heart, and other organs as patients age into adulthood.
This initiative, detailed in a recent scientific statement published in the AHA journal Circulation, seeks to address the challenges faced by the rapidly growing population of Fontan survivors. The statement, authored by a multidisciplinary group of experts, outlines the current understanding of long-term Fontan complications and establishes a roadmap for future research and clinical care strategies.
Key goals include developing standardized surveillance protocols for organ health, fostering specialized "Fontan clinics" for comprehensive care, and accelerating research into treatments for Fontan-associated liver disease and heart failure. The AHA emphasizes the urgent need for a coordinated effort among cardiologists, hepatologists, and other specialists to improve quality of life and long-term outcomes for these patients.
